TL;DR
This study uses a comprehensive, multi-omics approach to dissect the cellular response of Mycobacterium tuberculosis to inhibition of its essential Ser/Thr protein kinases, PknA and PknB. The findings reveal these kinases play a critical role in regulating cell envelope structure, stress responses, and nutrient transport, and uncover a novel regulatory link between kinase activity, MtrA phosphorylation, and mycolic acid metabolism, highlighting PknA and PknB as promising drug targets.
What Problem Does This Paper Address?
Tuberculosis remains a leading infectious disease killer globally, exacerbated by the rise of multidrug-resistant strains. This necessitates the development of novel therapeutic strategies, particularly those targeting essential bacterial pathways. Mycobacterium tuberculosis possesses a family of Ser/Thr protein kinases (STPKs), including the essential PknA and PknB, which are implicated in adapting to environmental signals through protein phosphorylation. However, a comprehensive understanding of the broad cellular functions regulated by these kinases and their interconnectedness with other cellular processes was lacking. This paper aims to bridge this knowledge gap by providing an integrated, multisystem view of how inhibiting PknA and PknB impacts M. tuberculosis physiology, thereby identifying new vulnerabilities for drug development.
Methods
The core of this study is a multisystem analysis employing a potent small-molecule inhibitor targeting PknA and PknB. This chemical inhibition approach offers advantages over genetic methods by allowing rapid and reversible inactivation of kinase activity, enabling the observation of both direct and downstream effects. The researchers integrated data from four key omics platforms:
- Phosphoproteomics: To identify changes in protein phosphorylation patterns, pinpointing direct kinase substrates.
- Transcriptomics (RNA-Seq): To measure global changes in gene expression.
- Proteomics: To quantify changes in protein abundance.
- Lipidomics and Metabolomics: To assess alterations in the cell envelope's lipid composition and intracellular small molecule profiles.
This integrated approach allowed for a holistic view of cellular responses. They also utilized CRISPR interference to validate the role of PknB in inhibitor susceptibility and employed in vitro biochemical assays (e.g., electrophoretic mobility shift assays, circular dichroism) to investigate specific molecular mechanisms, such as the effect of MtrA phosphorylation on DNA binding.
Datasets
The study generated and analyzed several large-scale datasets:
- Phosphoproteomic data: Identified 1,373 phosphopeptides corresponding to 1,241 unique phosphorylation sites on 470 proteins.
- Transcriptomic data: Identified 253 genes with increased expression and 45 genes with decreased expression in response to inhibitor treatment.
- Proteomic data: Detected 2,520 proteins, with 110 showing significantly decreased abundance and 82 showing significantly increased abundance.
- Lipidomic data: Identified over 10,000 unique molecular features, with 1,259 showing significant changes.
- Metabolomic data: Analyzed annotated intermediates of central carbon metabolism and PG precursor synthesis.
These datasets were compared with existing published datasets for transcriptomics under various stress conditions to contextualize the findings.
Key Insights and Ideas
- PknA and PknB are central regulators of the mycobacterial cell envelope: The study reveals that these kinases extensively control the synthesis, turnover, and composition of the cell wall, including peptidoglycan, lipids, and secreted proteins. This highlights the cell envelope as a critical interface for pathogen-host interaction that is directly modulated by these kinases.
- A novel link between kinase activity and a key two-component system (MtrA): A surprising finding was the identification of threonine phosphorylation at Thr213 of the response regulator MtrA, which was decreased upon PknA/PknB inhibition. This phosphorylation event was shown to negatively regulate MtrA's DNA binding activity, leading to the repression of genes involved in mycolic acid metabolism and cell wall synthesis. This uncovers a previously unknown layer of regulation for a crucial two-component system.
- Kinase inhibition impacts multiple essential cellular processes: Beyond the cell envelope, the study demonstrates that PknA and PknB influence fundamental processes like ATP synthesis, DNA synthesis, and translation, underscoring their essential role in bacterial growth and survival.
- Potential for targeted drug development: The identification of PknA and PknB as essential kinases with broad regulatory roles, coupled with the development of a potent and selective inhibitor, strongly supports their candidacy as targets for new antitubercular drugs.
Key Results
- Inhibition of PknA and PknB significantly reduced M. tuberculosis growth, with a minimal inhibitory concentration (MIC) of 4.5 µM for the active inhibitor.
- Depletion of PknB via CRISPR interference increased susceptibility to the inhibitor by 8-fold, confirming PknB's critical role.
- The multisystem analysis revealed widespread changes, including:
- Decreased phosphorylation of 48 proteins, many involved in cell wall synthesis, secretion, and cell division.
- Significant alterations in gene expression, with 253 genes upregulated and 45 downregulated.
- Changes in protein abundance, with 110 proteins decreased and 82 increased.
- Alterations in lipid profiles, notably increased free mycolic acids and changes in phosphatidylinositol mannosides (PIMs).
- Metabolic shifts, including increased intermediates in the TCA and methylcitrate cycles, suggesting lipid catabolism.
- The study identified a novel phosphorylation site (Thr213) on the MtrA response regulator, whose decreased phosphorylation upon kinase inhibition led to increased MtrA binding and repression of target genes, including fbpB.
- This cascade resulted in decreased expression of mycolyl transferase genes (fbpA, fbpB) and a reduction in trehalose dimycolate (TDM) levels.
Limitations and Future Work
The authors acknowledge that while their multisystem approach provides a comprehensive overview, some findings may represent an overestimate of direct effects due to the complexity of cellular responses. The study also notes that some observed changes, such as decreased ATP synthesis and translation pathway alterations, are also seen in response to other growth-arresting conditions, suggesting potential overlap in downstream pathways.
Future work could focus on:
- In-depth investigation of novel substrates: The identification of numerous phosphoproteins with decreased phosphorylation provides a rich resource for further targeted studies to elucidate their specific roles and regulation by PknA and PknB.
- Elucidating the precise mechanisms of MtrA regulation: Further studies could explore the structural and functional consequences of MtrA phosphorylation in more detail, including its interaction with other regulatory proteins.
- Exploring the therapeutic potential of PknA/PknB inhibitors: The study strongly supports the development of these kinases as drug targets, and future research could focus on optimizing inhibitor properties for clinical application.
- Investigating the role of PknA/PknB in different M. tuberculosis growth phases and environments: Understanding how kinase activity changes during infection or under specific stress conditions could reveal critical insights into pathogenesis and persistence.
Summary updated